Search Results
Robert Derham: Patent Exclusivity and the Orphan Drug Act
The Orphan Drug Act and Rare Disease Drug Pricing
Keeping up with the times: social media in the orphan drug industry / Robert Derham, Founder, CheckO
Orphan Drugs, Exclusivity, and Suing the FDA
Orphan Drug Exclusivity vs New Chemical Exclusivity
Gaming the System: Orphan Drugs Part 3
The Orphan Drug Machine
Amy Comstock Rick, JD | Drug Regulation & the Orphan Drug Act
Orphan Drug & Rare Disease Development: Understanding the European and US Regulatory Landscape
Orphan Drug Development, Pricing, and Access
Orphan Drugs -- small market/big opportunity / Craig Kephart, President , Centric Health Resources
Interview: Former Director FDA Office of Orphan Product Development| Rett Syndrome Research Trust
